erik alcantar
GlaxoSmithKline (Belgium)
Rixensart, Belgium
Review Editor
Cancer Immunity and Immunotherapy
Editors
GlaxoSmithKline (Belgium)
Rixensart, Belgium
Review Editor
Cancer Immunity and Immunotherapy
Institute of Tropical Disease, Airlangga University
Surabaya, Indonesia
Review Editor
Cancer Immunity and Immunotherapy
Biotech Foods S.L.
San Sebastián, Spain
Review Editor
Cancer Immunity and Immunotherapy
MUSC Health
Charleston, United States
Review Editor
Cancer Immunity and Immunotherapy
Amgen (United States)
Thousand Oaks, United States
Review Editor
Cancer Immunity and Immunotherapy
Medical College of Wisconsin
Milwaukee, United States
Review Editor
Cancer Immunity and Immunotherapy
National Heart, Lung, and Blood Institute (NIH)
Bethesda, United States
Review Editor
Cancer Immunity and Immunotherapy
University of Montreal Hospital Centre (CRCHUM)
Montreal, Canada
Review Editor
Cancer Immunity and Immunotherapy
Penn State State College of Medicine
Hershey, United States
Review Editor
Cancer Immunity and Immunotherapy
Department of Oncology, St. George’s University Hospitals NHS foundation Trust
London, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
King Abdulaziz University
Jeddah, Saudi Arabia
Review Editor
Cancer Immunity and Immunotherapy
Biocruces Bizkaia Health Research Institute
Barakaldo, Spain
Review Editor
Cancer Immunity and Immunotherapy
National Scientific and Technical Research Council (CONICET)
Buenos Aires, Argentina
Review Editor
Cancer Immunity and Immunotherapy
University of Coimbra
Coimbra, Portugal
Review Editor
Cancer Immunity and Immunotherapy
University of Florence
Florence, Italy
Review Editor
Cancer Immunity and Immunotherapy
Tehran University of Medical Sciences
Tehran, Iran
Review Editor
Cancer Immunity and Immunotherapy